# National Healthcare Corp (NHC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/national-healthcare-corp/ JSON: https://steadybase.io/company/national-healthcare-corp.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: NATIONAL HEALTHCARE CORP
- Ticker: NHC (NYSE)
- SEC CIK: 0001047335
- Industry: Services-Skilled Nursing Care Facilities (SIC 8051)
- Headquarters: Murfreesboro, TN
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: nhccare.com
- Investor relations: https://nhccare.com/investor-relations/
- LinkedIn: https://www.linkedin.com/company/nhc-healthcare-corporation
- Next earnings date: Nov 6, 2026

## Key facts

- Revenue: $1.5B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/0001437749-26-005910-index.html
- Operating income: $128.4M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/0001437749-26-005910-index.html
- Net income: $120.0M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/0001437749-26-005910-index.html
- SG&A: $27498.0B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/0001437749-26-005910-index.html
- Employees: 15,278 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/nhc20251231_10k.htm
- Shares outstanding: 15,664,304 as of Nov 2, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926035256/0001437749-26-035256-index.html
- Auditor: Deloitte & Touche LLP, Nashville, Tennessee, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/nhc20251231_10k.htm

## Business

National HealthCare Corporation, which we also refer to as NHC or the Company, began business in 1971. Our principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Our business activities include providing sub–acute and post–acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, home health care services, hospice services, and behavioral health services.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/nhc20251231_10k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $1.5B | $128.4M | $120.0M | $27498.0B |
| Dec 31, 2024 | $1.3B | $89.9M | $101.9M | $26236.0B |
| Dec 31, 2023 | $1.1B | $57.5M | $66.8M | $21412.0B |
| Dec 31, 2022 | $1.1B | $31.9M | $22.4M | $20.7M |
| Dec 31, 2021 | $1.1B | $50.9M | $138.6M | $20.2M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/national-healthcare-corp.json

## Officers and directors

- Stephen Fowler Flatt, CEO. Source: Form 4 filed Aug 20, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926028642/0001437749-26-028642-index.htm
- Brian F. Kidd, SVP, CFO. LinkedIn: https://linkedin.com/in/brian-kidd-97866479. Source: Form 4 filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926030323/0001437749-26-030323-index.htm
- Robert Michael Ussery, President & COO. Source: Form 4 filed Jan 5, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926000387/0001437749-26-000387-index.htm
- Josh A. McCreary, Senior VP & General Counsel. LinkedIn: https://linkedin.com/in/josh-mccreary-b6aa46301. Source: Form 4 filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926030334/0001437749-26-030334-index.htm
- Vicki L. Dodson, Sr.VP Patient Srvcs. LinkedIn: https://linkedin.com/in/vicki-dodson-442158313. Source: Form 4 filed Sep 23, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926031086/0001437749-26-031086-index.htm
- Ben Anderson Flatt Sr, Senior VP & CIO. Source: Form 4 filed Sep 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926029512/0001437749-26-029512-index.htm
- Timothy J. Shelly, Sr.VP Operations. Source: Form 4 filed May 20, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000143774926017945/0001437749-26-017945-index.htm
- B. Anderson Flatt, Sr., Named in proxy. Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- David R. Gifford, M.D., Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Emil E. Hassan, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Lisa Piercey, M.D., Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- R. Michael Ussery, Named in proxy. Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Richard F. LaRoche, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Robert Adams, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Sandra Y. Trail, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- Stephen F. Flatt, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- W. Andrew Adams, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm
- William A. Adams, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm

## Recent 8-K events

- Nov 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926035417/nhc20261104_8k.htm
- Nov 6, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926035415/nhc20261104c_8k.htm
- Aug 11, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926026960/nhc20260806_8k.htm
- Aug 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926026957/nhc20260806c_8k.htm
- Jul 1, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 2.03, Creation of a direct financial obligation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926022306/nhc20260630_8k.htm
- May 27, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926018604/nhc20260527_8k.htm
- May 15, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926017374/nhc20260515_8k.htm
- May 13, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926016571/nhc20260512_8k.htm
- May 8, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/nhc20260506c_8k.htm
- May 7, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926015606/nhc20260506_8k.htm

## Insider trades (Form 4)

- Sep 22, 2026: Vicki L. Dodson (Sr.VP Patient Srvcs) sold 4,834 shares, about $1.1M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926031086/0001437749-26-031086-index.htm
- Sep 11, 2026: Brian F. Kidd (SVP, CFO) sold 6,813 shares, about $1.5M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926030323/0001437749-26-030323-index.htm
- Sep 10, 2026: Josh A. McCreary (Senior VP & General Counsel) sold 2,719 shares, about $609,673. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926030334/0001437749-26-030334-index.htm
- Aug 28, 2026: Ben Anderson Flatt Sr (Senior VP & CIO) sold 7,000 shares, about $1.6M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926029512/0001437749-26-029512-index.htm
- Aug 25, 2026: David R. Gifford (Director) sold 1,779 shares, about $401,022. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926029198/0001437749-26-029198-index.htm
- Aug 19, 2026: Stephen Fowler Flatt (CEO) sold 1,500 shares, about $355,620. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926028642/0001437749-26-028642-index.htm
- Jun 22, 2026: Emil E. Hassan (Director) sold 5,937 shares, about $1.2M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926021438/0001437749-26-021438-index.htm
- Jun 16, 2026: Emil E. Hassan (Director) sold 1,563 shares, about $312,569. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926021139/0001437749-26-021139-index.htm
- Jun 1, 2026: Lisa Piercey (Director) bought 949 shares, about $174,863. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926019170/0001437749-26-019170-index.htm
- May 21, 2026: Richard F. Laroche Jr (Director) sold 7,500 shares, about $1.5M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926018248/0001437749-26-018248-index.htm
- May 19, 2026: Timothy J. Shelly (Sr.VP Operations) sold 1,853 shares, about $365,449. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774926017945/0001437749-26-017945-index.htm
- Dec 17, 2025: Timothy J. Shelly (Sr.VP Operations) sold 2,454 shares, about $342,137. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774925038286/0001437749-25-038286-index.htm
- Nov 25, 2025: Emil E. Hassan (Director) sold 7,500 shares, about $1.0M. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774925036441/0001437749-25-036441-index.htm
- Nov 21, 2025: Stephen Fowler Flatt (CEO) sold 1,000 shares, about $130,330. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774925036333/0001437749-25-036333-index.htm
- Nov 12, 2025: Emil E. Hassan (Director) sold 5,500 shares, about $731,500. Source: https://www.sec.gov/Archives/edgar/data/1047335/000143774925034547/0001437749-25-034547-index.htm

## Latest filings

- 8-K filed Aug 11, 2026: https://www.sec.gov/Archives/edgar/data/1047335/000143774926026960/nhc20260806_8k.htm
- 10-K filed Feb 26, 2026: https://www.sec.gov/Archives/edgar/data/1047335/000143774926005910/nhc20251231_10k.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1047335/000143774926026199/nhc20260630_10q.htm
- DEF 14A filed Apr 2, 2026: https://www.sec.gov/Archives/edgar/data/1047335/000114036126013005/ny20062027x1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/